United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications and usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets are administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone [see warnings and precautions (5.1)]. - eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women are insu

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications and usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets are administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone [see warnings and precautions (5.1)]. - eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women are

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications and usage eszopiclone tablet is indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone is contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone [see warnings and precautions (5.1)]. - eszopiclone is contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)] . 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women are insufficient to identi

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications and usage eszopiclone tablet is indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone is contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone [see warnings and precautions (5.1)]. - eszopiclone is contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)] . 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women are insufficient to identi

United States - English - NLM (National Library of Medicine)

direct rx - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). eszopiclone is contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone [see warnings and precautions (5.1)]. eszopiclone is contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)] . 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women are insufficient to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction s

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications and usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone tablets [see warnings and precautions (5.1)]. - eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications and usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone tablets [see warnings and precautions (5.1)]. - eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications & usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). • eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone tablets [see warnings and precautions (5.1)]. • eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant wo

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - 1 indications & usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone tablets [see warnings and precautions (5.1)]. - eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women a

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - indications & usage eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). - eszopiclone tablets are contraindicated in patients who have experienced complex sleep behaviors after taking eszopiclone tablets [see warnings and precautions (5.1)]. - eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. 8.1 pregnancy risk summary available pharmacovigilance data with eszopiclone use in pregnant women a